128 related articles for article (PubMed ID: 1973719)
21. Characterization of lymphoid cells in the thyroid of patients with Graves' disease.
Warford A; McLachlan SM; Malcolm AJ; Young ET; Farndon JR; Rees Smith B
Clin Exp Immunol; 1984 Sep; 57(3):626-32. PubMed ID: 6235996
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical analysis of intrathyroidal lymphocytes in Graves' disease: evidence of activated T cells and production of interferon-gamma.
Margolick JB; Weetman AP; Burman KD
Clin Immunol Immunopathol; 1988 May; 47(2):208-18. PubMed ID: 2964967
[TBL] [Abstract][Full Text] [Related]
23. Differences in thyroid-infiltrating B lymphocytes in patients with Graves' disease: relationship to autoantibody detection.
Segundo C; Rodríguez C; Aguilar M; García-Poley A; Gavilán I; Bellas C; Brieva JA
Thyroid; 2004 May; 14(5):337-44. PubMed ID: 15186609
[TBL] [Abstract][Full Text] [Related]
24. [The relationship between intrathyroidal dendritic cells and humoral immune disorder in Graves' disease].
Zhang HJ; Li DM; Gao DL; Zhang L; Cao J; Zhao ZH; Zhang YH; Xu L
Zhonghua Nei Ke Za Zhi; 2005 Feb; 44(2):122-4. PubMed ID: 15840225
[TBL] [Abstract][Full Text] [Related]
25. [An immunohistochemical study on human leucocyte antigen-DR in Hashimoto thyroiditis and Graves disease].
Zhang H; Li D; Ouyang A
Zhonghua Nei Ke Za Zhi; 1996 May; 35(5):303-5. PubMed ID: 9387612
[TBL] [Abstract][Full Text] [Related]
26. In situ immune complexes, lymphocyte subpopulations, and HLA-DR-positive epithelial cells in Hashimoto thyroiditis.
Aichinger G; Fill H; Wick G
Lab Invest; 1985 Feb; 52(2):132-40. PubMed ID: 3881622
[TBL] [Abstract][Full Text] [Related]
27. Thyroid xenografts from patients with Graves' disease in severe combined immunodeficient mice and NIH-beige-nude-xid mice.
Mukuta T; Arreaza G; Nishikawa M; Resetkova E; Jamieson C; Tamai H; Volpé R
Clin Invest Med; 1997 Feb; 20(1):5-15. PubMed ID: 9013039
[TBL] [Abstract][Full Text] [Related]
28. Increase of peripheral B lymphocytes in Graves' disease.
Mori H; Amino N; Iwatani Y; Kabutomori O; Asari S; Motoi S; Miyai K; Kumahara Y
Clin Exp Immunol; 1980 Oct; 42(1):33-40. PubMed ID: 6970099
[TBL] [Abstract][Full Text] [Related]
29. Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease.
Matsunaga M; Eguchi K; Fukuda T; Kurata A; Tezuka H; Shimomura C; Otsubo T; Ishikawa N; Ito K; Nagataki S
J Clin Endocrinol Metab; 1986 Apr; 62(4):723-8. PubMed ID: 3081570
[TBL] [Abstract][Full Text] [Related]
30. Natural killer and natural killer-like cell activity of peripheral blood and intrathyroidal mononuclear cells from patients with Graves' disease.
Tezuka H; Eguchi K; Fukuda T; Otsubo T; Kawabe Y; Ueki Y; Matsunaga M; Shimomura C; Nakao H; Ishikawa N
J Clin Endocrinol Metab; 1988 Apr; 66(4):702-7. PubMed ID: 3257969
[TBL] [Abstract][Full Text] [Related]
31. Reconstitution of severe combined immunodeficient mice with intrathyroidal lymphocytes of thyroid xenografts from patients with Hashimoto's thyroiditis.
Akasu F; Morita T; Resetkova E; Miller N; Akasu R; Jamieson C; Volpé R
J Clin Endocrinol Metab; 1993 Jan; 76(1):223-30. PubMed ID: 7678424
[TBL] [Abstract][Full Text] [Related]
32. Demonstration of circulating autoantibodies against the plasma membrane of isolated thyroid cells in Graves' disease.
Hopf U; Fiek T; Grün R; Zuschneid W
J Clin Lab Immunol; 1982 Oct; 9(1):49-53. PubMed ID: 6757440
[TBL] [Abstract][Full Text] [Related]
33. Effect of removing human Graves' thyroid xenografts after eight weeks in nude mice and rexenografting them into SCID mice.
Yoshikawa N; Arreaza G; Morita T; Mukuta T; Resetkova E; Akasu F; Miller N; Jamieson C; Volpé R
J Clin Endocrinol Metab; 1994 Feb; 78(2):367-74. PubMed ID: 8106624
[TBL] [Abstract][Full Text] [Related]
34. The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells.
McLachlan SM; Nagayama Y; Pichurin PN; Mizutori Y; Chen CR; Misharin A; Aliesky HA; Rapoport B
Endocrinology; 2007 Dec; 148(12):5724-33. PubMed ID: 17823263
[TBL] [Abstract][Full Text] [Related]
35. Thyroid autoantibody synthesis by cultures of thyroid and peripheral blood lymphocytes. I. Lymphocyte markers and response to pokeweed mitogen.
McLachlan SM; Dickinson AM; Malcolm A; Farndon JR; Young E; Proctor SJ; Smith BR
Clin Exp Immunol; 1983 Apr; 52(1):45-53. PubMed ID: 6602673
[TBL] [Abstract][Full Text] [Related]
36. An investigation of pedigrees of 110 patients with Graves' disease and the clinical significance of determinations of antithyroid antibodies of their first-degree relatives.
Wang DQ; Wang JZ; Ren JM; Zhou XT; Peng WC
Chin Med J (Engl); 1994 Nov; 107(11):817-21. PubMed ID: 7867387
[TBL] [Abstract][Full Text] [Related]
37. HLA antigens and thyroid autoantibodies in patients with Graves' disease and their first degree relatives.
Mather BA; Roberts DF; Scanlon MF; Mukhtar ED; Davies TF; Smith BR; Hall R
Clin Endocrinol (Oxf); 1980 Feb; 12(2):155-63. PubMed ID: 6893172
[TBL] [Abstract][Full Text] [Related]
38. The changes of serum titers of thyroid antibodies in patients of Graves' disease with hyperthyroidism after treatments with antithyroid drugs.
Huang CS; Tseng FY; Chang TC; Chang CC; Chen FW; Torng JK
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1983 Nov; 16(4):277-82. PubMed ID: 6202467
[TBL] [Abstract][Full Text] [Related]
39. Development of a human monoclonal antibody from a Graves' disease patient that identifies a novel thyroid membrane antigen.
Baker JR; Saunders NB; Kaulfersch W; Burman KD
J Immunol; 1988 Apr; 140(8):2593-9. PubMed ID: 2895790
[TBL] [Abstract][Full Text] [Related]
40. Increment in the Ta1+ cells in the peripheral blood and thyroid tissue of patients with Graves' disease.
Eguchi K; Ueki Y; Shimomura C; Otsubo T; Nakao H; Migita K; Kawakami A; Matsunaga M; Tezuka H; Ishikawa N
J Immunol; 1989 Jun; 142(12):4233-40. PubMed ID: 2542405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
